Yaz & Yasmin Facts:
- Yaz is the top-selling birth control pill in the United States.
- Yaz owes much of its popularity to multimillion-dollar ad campaigns that have promoted the drug as a quality-of-life treatment to combat acne and severe premenstrual depression.
- Yaz is manufactured by Bayer HealthCare Pharmaceuticals which is the pharmaceutical division of Bayer HealthCare AG.
- Bayer HealthCare AG is owned by Bayer AG with corporate headquarters in Leverkusen, Germany.
- Yaz and Yasmin ranked second highest in 2011 for the number of complications reported to the FDA.
- Consumers might remember the popular “Not Gonna Take It” and “Balloons” commercials advertising Yaz.
- The Yaz franchise had $1.8 billion in worldwide sales in 2008, based on Bayer’s successful positioning of Yasmin and Yaz as the go-to drug brands for women under 35.
- A former FDA commissioner said that Bayer researchers found increased reports of blood clots in women using Yasmin in the United States, compared with those using three other pills, but did not provide that information to the FDA in a 2004 safety review.
- The British Medical Journal and FDA both warn that drugs like Yaz containing the hormone drospirenone could increase the risk of blood clots by as much as 74%.
- Blood clots can cause serious conditions like stroke, DVT or pulmonary embolism resulting in severe medical complications and even death.
The FDA’s most serious label, the black-box warning, appears on all Yaz and Yasmin packaging, cautioning women who smoke about an increased risk of serious cardiovascular side effects.